Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 22% ± 5% | |
| epithelial cell | 5 studies | 39% ± 22% | |
| fibroblast | 4 studies | 17% ± 2% | |
| natural killer cell | 3 studies | 18% ± 4% | |
| B cell | 3 studies | 21% ± 1% | |
| basal cell | 3 studies | 26% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 1495.38 | 21 / 21 | 100% | 14.43 | 504 / 504 |
| esophagus | 100% | 1637.53 | 1445 / 1445 | 100% | 15.75 | 183 / 183 |
| intestine | 100% | 1738.96 | 966 / 966 | 100% | 13.83 | 527 / 527 |
| ovary | 100% | 1224.67 | 180 / 180 | 100% | 8.21 | 430 / 430 |
| stomach | 100% | 1330.13 | 359 / 359 | 100% | 14.19 | 286 / 286 |
| breast | 100% | 1362.88 | 459 / 459 | 100% | 13.53 | 1117 / 1118 |
| lung | 100% | 1228.79 | 577 / 578 | 100% | 13.34 | 1155 / 1155 |
| uterus | 100% | 1397.22 | 170 / 170 | 100% | 13.28 | 458 / 459 |
| prostate | 100% | 1399.82 | 245 / 245 | 100% | 8.94 | 500 / 502 |
| pancreas | 100% | 1034.51 | 328 / 328 | 99% | 10.04 | 177 / 178 |
| brain | 99% | 809.44 | 2622 / 2642 | 100% | 10.94 | 705 / 705 |
| thymus | 100% | 1195.58 | 652 / 653 | 99% | 9.57 | 600 / 605 |
| kidney | 100% | 1426.63 | 89 / 89 | 99% | 9.35 | 890 / 901 |
| liver | 100% | 912.25 | 226 / 226 | 97% | 6.93 | 394 / 406 |
| skin | 100% | 1748.70 | 1809 / 1809 | 96% | 10.58 | 452 / 472 |
| adrenal gland | 100% | 1432.17 | 258 / 258 | 92% | 4.86 | 211 / 230 |
| adipose | 100% | 1323.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 9.99 | 29 / 29 |
| spleen | 100% | 1492.09 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 11.00 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.06 | 1 / 1 |
| blood vessel | 100% | 1156.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1066.94 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 757.11 | 839 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 89% | 987.13 | 828 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 5.05 | 66 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030490 | Biological process | maturation of SSU-rRNA |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0003724 | Molecular function | RNA helicase activity |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | DDX52 |
| Protein name | Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52) DExD-box helicase 52 (Probable ATP-dependent RNA helicase DDX52) RNA helicase (EC 3.6.4.13) |
| Synonyms | ROK1 HUSSY-19 |
| Description | FUNCTION: Required for efficient ribosome biogenesis (By similarity). May control cell cycle progression by regulating translation of mRNAs that contain a terminal oligo pyrimidine (TOP) motif in their 5' UTRs, such as GTPBP4 (By similarity). . |
| Accessions | ENST00000616646.4 ENST00000631762.1 ENST00000633356.1 ENST00000632030.1 ENST00000615769.2 A0A087WTD6 ENST00000633389.1 ENST00000613633.1 A0A087X1P7 ENST00000612255.4 ENST00000617633.5 A0A087X069 A0A087X121 Q9Y2R4 ENST00000620209.4 |
